Sublingual immunotherapy provides long‐term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real‐world database analysis

BACKGROUND: Allergy immunotherapy (AIT) is the only treatment for allergic rhinitis (AR) and/or allergic asthma (AA) with long‐term efficacy. However, there are few real‐life data on the progression of AR and/or AA in patients receiving AIT. OBJECTIVES: To assess the real‐world, long‐term efficacy o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zielen, S., Devillier, P., Heinrich, J., Richter, H., Wahn, U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763412/
https://www.ncbi.nlm.nih.gov/pubmed/28561266
http://dx.doi.org/10.1111/all.13213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763412/
https://www.ncbi.nlm.nih.gov/pubmed/28561266
http://dx.doi.org/10.1111/all.13213

Ejemplares similares